Disable all preview features

Health : Medical Research (Grantmaking/Grants Payable)

Cancer Research Institute

The Leader in Immunotherapy

four stars

93.60

29 Broadway, Floor 4 New York, NY 10006
tel: (800) 992-2623   Web Site
EIN: 13-1837442

Board Leadership
Paul C. Shiverick and Andrew K. Tsai
Chairmen

CEO
Jill O'Donnell-Tormey
Chief Executive Officer & Director of Scientific Affairs

  Score
(out of 100)
Rating
Overall Score & Rating 93.60 four stars
  Financial 90.96 four stars
  Accountability & Transparency 100.00 four stars
This rating was published 11/01/2020 and includes data from FY2019, the most recent 990 received at that time.

Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer.

Established in 1953, the Cancer Research Institute (CRI) is a nonprofit organization dedicated exclusively to harnessing the immune system's power to conquer all cancers. We fund the most innovative research by young scientists, invest in clinical studies of promising new treatments, and serve as a bridge between the lab and the clinic. CRI has invested $445 million to fund more than 3,200 scientists around the world. With 68 years' experience funding research on the immune system and cancer, CRI is leading the way and ushering in a new era when patients with all types of cancer can be treated and cured with immunotherapy. Moreover, CRI-funded research is also contributing to efforts to combat and cure autoimmune and infectious diseases, including COVID-19.

Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer.

Established in 1953, the Cancer Research Institute (CRI) is a nonprofit organization dedicated exclusively to harnessing the immune system's power to conquer all cancers. We fund the most innovative research by young scientists, invest in clinical studies of promising new treatments, and serve as a bridge between the lab and the clinic. CRI has invested $445 million to fund more than 3,200 scientists around the world. With 68 years' experience funding research on the immune system and cancer, CRI is leading the way and ushering in a new era when patients with all types of cancer can be treated and cured with immunotherapy. Moreover, CRI-funded research is also contributing to efforts to combat and cure autoimmune and infectious diseases, including COVID-19.

Financial

four stars

90.96

Accountability & Transparency

four stars

100.00

This rating was published 11/01/2020 and includes data from FY2019, the most recent 990 received at that time.
Overall Rating Chart
  Program Expenses
(Percent of the charity's total expenses spent on the programs
and services it delivers)
85.6%
  Administrative Expenses 5.6%
  Fundraising Expenses 8.7%
  Fundraising Efficiency $0.09
  Working Capital Ratio (years) 1.85
  Program Expenses Growth 4.0%
  Liabilities to Assets 53.9%
All data for Financial Performance Metrics calculations was provided by Cancer Research Institute on recent 990s filed with the IRS.
All data for Financial Performance Metrics calculations was provided by Cancer Research Institute on recent 990s filed with the IRS.

Highly Rated

Charity Name & State Overall Score Overall Rating
Cancer Research Institute (NY) 93.60 four stars
Israel Cancer Association USA (FL) 92.24 four stars
Damon Runyon Cancer Research Foundation (NY) 92.61 four stars
Swim Across America (NC) 95.47 four stars
Pediatric Cancer Research Foundation (CA) 89.61 three stars

Compare These Charities (Highly Rated)

REVENUE  
Contributions  
   Contributions, Gifts & Grants $37,600,369
   Federated Campaigns $515,069
   Membership Dues $0
   Fundraising Events $2,261,152
   Related Organizations $0
   Government Grants $0
Total Contributions $40,376,590
   Program Service Revenue $0
Total Primary Revenue $40,376,590
   Other Revenue $1,619,102
TOTAL REVENUE $41,995,692
   
EXPENSES  
   Program Expenses $30,222,868
   Administrative Expenses $1,788,067
   Fundraising Expenses $2,737,455
TOTAL FUNCTIONAL EXPENSES $34,748,390
   
Payments to Affiliates $0
Excess (or Deficit) for the year $7,247,302
   
Net Assets $58,798,343

Program names and associated costs are listed for the top programs as reported on the charity's most recently filed Form 990. The top programs displayed will include the largest three programs, or those programs covering at least 60% of the charity's total expenses, whichever comes first.

Program Name Amount Spent % of Program Expenses
Clinical Accelerator Program $10,371,973 34.3%
Grants $6,250,000 20.7%
Postdoctoral Fellowship Program $4,769,750 15.8%

Ratings History
Cancer Research Institute has received 8 consecutive 4-star ratings from Charity Navigator.

Form 990 FYE Date Published Overall Score Overall Rating
CN 2.1
2019-06 11/01/2020 93.60 four stars
2018-06 07/01/2019 94.12 four stars
2017-06 12/01/2018 92.18 four stars
2016-06 06/01/2017 94.69 four stars
2015-06 06/01/2016 94.69 four stars
 
CN 2.0
2014-06 09/01/2015 99.05 four stars
2013-06 06/01/2014 95.76 four stars
2012-06 06/01/2013 94.25 four stars
2011-06 09/01/2012 89.29 three stars
2011-06 05/01/2012 91.06 four stars
2010-06 09/20/2011 89.34 three stars
 
CN 1.0
2010-06 07/01/2011 83.65 three stars
2009-06 11/24/2010 79.90 two stars
2008-06 06/01/2009 85.31 three stars
2007-06 09/01/2008 94.49 four stars
2006-06 04/01/2007 88.17 three stars
2005-06 03/01/2006 85.65 three stars
2004-06 05/01/2005 76.10 two stars
2003-06 03/01/2004 79.59 two stars
2002-06 04/15/2003 88.94 three stars

The data displayed on this tab is provided by the IRS in the form of Publication 78 and the Business Master File (BMF).

EIN 13-1837442
Name in IRS Master File CANCER RESEARCH INSTITUTE INC
NTEE Code H30
NTEE Classification Cancer Research
NTEE Type Medical Research
Classification Charitable Organization
Subsection 501(c)(3)  (View the list of codes)
Activities (161) Scientific research (diseases)
(180) Contact or sponsored scientific research for industry
Foundation Status Organization which receives a substantial part of its support from a governmental unit or the general public   170(b)(1)(A)(vi)
Deductibility Contributions are deductible
Affiliation Independent - the organization is an independent organization or an independent auxiliary (i.e., not affiliated with a National, Regional, or Geographic grouping of organizations).
Group Name [Not Applicable]
Ruling Date November, 1953
Filing Requirement 990 (all other) or 990EZ return
Fiscal Year End June
IRS Forms 990
(provided courtesy of Foundation Center)
(Log In or Register Now to View Forms 990!)
  • June, 2018
  • June, 2017
  • June, 2016
  • June, 2015
  • June, 2014
Compensation % of Expenses Paid to Title
$456,388 1.31% Jill O'Donnell-Tormey CEO

Highly Rated

Charity Name & State Overall Score Overall Rating
Cancer Research Institute (NY) 93.60 four stars
The Multiple Myeloma Research Foundation (CT) 96.25 four stars
CURE Childhood Cancer (GA) 96.46 four stars
Samuel Waxman Cancer Research Foundation (NY) 89.66 three stars
Rally Foundation (GA) 98.23 four stars

Compare These Charities (Highly Rated)

This charity has an official representative registered with Charity Navigator.

Charity Contact Info

Cancer Research Institute
29 Broadway, Floor 4
New York, NY 10006
tel: (800) 992-2623
fax: (212) 832-9376
EIN: 13-1837442

Visit Web Site

Board Leadership

Paul C. Shiverick and Andrew K. Tsai
Chairmen

CEO

Jill O'Donnell-Tormey
Chief Executive Officer & Director of Scientific Affairs

Join Our Mailing List

Join over 400,000 other informed givers and get updates on charity ratings, new features, hot topics, and tips for donating.